|
Jun 19
|
Q1 Rundown: Royalty Pharma (NASDAQ:RPRX) Vs Other Branded Pharmaceuticals Stocks
|
|
Jun 18
|
Bristol-Myers Squibb (NYSE:BMY) Declares US$0.62 Common and US$0.50 Preferred Dividends
|
|
Jun 17
|
Bristol Myers Squibb Announces Dividend
|
|
Jun 17
|
Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly
|
|
Jun 17
|
Bristol Myers Squibb Presents Promising Blood Cancer Drug Data at EHA Congress
|
|
Jun 16
|
Bristol Myers Squibb (BMY) Stock Drops Despite Market Gains: Important Facts to Note
|
|
Jun 16
|
Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi (lisocabtagene maraleucel)
|
|
Jun 16
|
2 Beaten-Down Dividend Stocks to Buy Right Now
|
|
May 26
|
Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?
|
|
May 23
|
Bristol-Myers Squibb (NYSE:BMY) Showcases Breakthrough Oncology Data at ASCO 2025 Meeting
|
|
May 23
|
EXEL Reports Superior Efficacy Data From Kidney Cancer Study Cohort
|
|
May 23
|
With 81% ownership, Bristol-Myers Squibb Company (NYSE:BMY) boasts of strong institutional backing
|
|
May 22
|
Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline
|
|
May 22
|
1 Safe-and-Steady Stock to Own for Decades and 2 to Think Twice About
|
|
May 22
|
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)
|
|
May 21
|
Bristol Myers Squibb to Participate in the Bernstein 41st Annual Strategic Decisions Conference
|
|
May 20
|
Here's How You Can Earn $100 In Passive Income By Investing In Bristol-Myers Squibb Stock
|
|
Apr 14
|
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
|
|
Apr 14
|
BMS’ Opdivo combo approved in US for hepatocellular carcinoma
|
|
Apr 11
|
Biotech Stock Bounces From Support, Shows Relative Strength Amid Volatile Market
|